معرفی
Dr. Katherine Chapman is a Senior Lecturer in Biomedical Sciences at Swansea University's School of Medicine. She leads the BSc Applied Medical Sciences program and serves as the School's Employability Lead. Her academic background includes a BSc in Biochemistry from the University of Bath and a PhD in genetic toxicology from Swansea University. She holds a PGCert in Teaching in Higher Education and is a Senior Fellow of the Higher Education Academy.
Her research focuses on in vitro carcinogenicity testing, mitochondrial toxicity, and the development of novel toxicology models. Notable contributions include creating a 3D tissue model for assessing genotoxicity and a multi-endpoint carcinogenicity test. Chapman actively collaborates with organizations like the UK Environmental Mutagens Association and the European Chemicals Agency (ECHA), co-leading the UK Quality Assurance Agency's Program Leaders Network.
Her work has been recognized with awards such as the Lush International Young Researcher Award (2016) and the UK Environmental Mutagens Association Young Scientist Award (2020). Her research spans topics like nanoparticle genotoxicity, chronic dosing effects, and mitochondrial dysfunction mechanisms. Chapman has secured grants from Diabetes UK and the NC3Rs to advance her studies on hyperglycaemia and environmental chemical impacts on human cells.
She supervises multiple PhD and MSc students, mentoring projects on topics like carcinogen metabolism, deep learning in genotoxicity analysis, and mitochondrial DNA effects. Beyond academia, Chapman advocates for 3Rs-compliant research practices and contributes to international conferences, emphasizing translational toxicology advancements.
